Letter from the Editor in Chief

DOI: 10.19102/icrm.2018.090406

MOUSSA MANSOUR, MD, FHRS, FACC

Left Atrial Appendage Occlusion: What Are the Options and Where is the Evidence?

DOI: 10.19102/icrm.2018.090402

RAGHURAM CHAVA, MD,¹ MOHIT K. TURAGAM, MD,² and DHANUNJAYA (DJ) LAKKIREDDY, MD, FACC, FHRS^1,3

¹Department of Internal Medicine, MedStar Harbor Hospital, Baltimore, MD, USA

²Section of Electrophysiology, Mount Sinai Hospital, New York, NY, USA

³Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, KS, USA

Stroke Prevention in Patients with Atrial Fibrillation

DOI: 10.19102/icrm.2018.090405

Reversal Agents: What We Have and What We Can Expect

DOI: 10.19102/icrm.2018.090403

CHRISTIAN T. RUFF, MD, MPH¹

¹TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation

DOI: 10.19102/icrm.2018.090404

JASON D. MATOS, MD,^1* JONATHAN W. WAKS, MD,^1* and PETER J. ZIMETBAUM, MD¹

¹Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Cardiac Resynchronization Therapy Upgrade in a Patient with Dextrocardia and Situs Inversus Totalis, Facilitated by Coronary Sinus Cannulation with Electrophysiology Catheters from Both Femoral and Axillary Venous Approaches

DOI: 10.19102/icrm.2018.090401

MAZDA MOTALLEBI, MD, FHRS, FACC, CCDS^1,2 and NARGES FEIZABADI, MSN, FNC-C, CVNP-BC¹

¹Cardiovascular and Electrophysiology Services, CareMore Health Plan, Los Angeles, CA, USA

²Cardiac Electrophysiology Laboratory, Lakewood Regional Medical Center, Lakewood, CA, USA